Morbidly Obese, Diabetic, Younger, and Unilateral Joint Arthroplasty Patients Have Elevated Total Joint Arthroplasty Infection Rates

Journal of Arthroplasty

Volumn 24, Issue 6 SUPPL., 2009, Pages 84-88

  Malinzak, Robert A ^a   Ritter, Merrill A ^a   Berend, Michael E ^a   Meding, John B ^a   Olberding, Emily M ^a   Davis, Kenneth E ^a  

^a CENTER FOR HIP AND KNEE SURGERY   (United States)

Author keywords

age; diabetes; hip arthroplasty; infection; knee arthroplasty; obesity

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BONE NECROSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; OSTEOARTHRITIS; POSTOPERATIVE INFECTION; PROSTHESIS INFECTION; RHEUMATOID ARTHRITIS; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; PREVALENCE; PROSTHESIS-RELATED INFECTIONS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 68949169204     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2009.05.016     Document Type: Article

References (28)

1. Gill G.S., and Mills D.M. Long-term follow-up evaluation of 1000 consecutive cemented total knee arthroplasties. Clinical Orthopedics 273 (1991) 66
2. Mauerhan D.R., Nelson C.L., Smith D.L., et al. Prophylaxis against infection in total joint arthroplasty. One day of cefuroxime compared with three days of cefazolin. J Bone Jt Surg [Am] 76 (1994) 39
3. Murray W.R. Use of antibiotic-containing bone cement. Clinical Orthopedics 190 (1984) 89
4. Lecuire F., Gontier D., Carrere J., et al. Ten-year surveillance of nosocomial surgical site infections in an orthopedic surgery department. Rev Chir Orthop Reparatrice Appar Mot 89 (2003) 479
5. Scott W.N., Rubinstein M., and Scuderi G. Results after knee replacement with a posterior cruciate-substituting prosthesis. J Bone Jt Surg [Am] 70-A (1988) 1163
6. Steffen R., von Bremen-Kuhne R., and Eppe T. Complications after total knee arthroplasty. Zentralbl Chir 128 (2003) 74
7. Tang W.M., Chiu K.Y., Ng T.P., et al. Efficacy of a single does of cefazolin as a prophylactic antibiotic in primary arthroplasty. J Arthroplast 18 (2003) 714
8. Chiu F.Y., Chen C.M., Lin C.F.J., et al. Cefuroxime-impregnated cement in primary total knee arthroplasty. A prospective, randomized study of three hundred and forty knees. J Bone Joint Surg [Am] 84-A (2002) 759
9. Chiu F.Y., Lin C.F., Chen C.M., et al. Cefuroxime-impregnated cement at primary total knee arthroplasty in diabetes mellitus. A prospective, randomized study. J Bone Joint Surg [Br] 83 (2001) 691
10. Meding J.B., Reddleman K., Keating M.E., et al. Total knee replacement in patients with diabetes mellitus. Clinical Orthopedics 416 (2003) 208
11. Menon T.J., Thjellesen D., and Wroblewski B.M. Charnley low-friction arthroplasty in diabetic patients. J Bone Jt Surg [Br] 65 (1983) 580
12. Bourne R.B. Prophylactic use of antibiotic bone cement. An emerging standard-in the affirmative. J Arthroplast 19 Suppl (2004) 69
13. Peersman G. Infection in total knee replacement. Clin Orthop Relat Res 392 (2001) 15
14. Eveillard M. Risk of deep infection in first-intention total hip replacement. Evaluation concerning a continuous series of 790 cases (French). Presse Med 30 (2001) 1868
15. Clyburn T.A. Timing of prophylactic antibiotics in TJA. AAOS Bull (2005) 13
16. Rosenberg A.D., Wambold D., Fraemer L., et al. Ensuring appropriate timing of antimicrobial prophylaxis. JBJS 90-A (2008) 226
17. Meding J.B., Klay M., Healy A., et al. The prescreening history and physical in elective total joint arthroplasty. J Arthroplast 22 Suppl 2 (2007) 21
18. Debarge R., Nicolle M.C., Pinaroli A., et al. Surgical site infection after total knee arthroplasty: a monocenter analysis of 923 first-intention implantations. Rev Chir Orthop Reparatrice Appar Mot 93 (2007) 582 [French]
19. Azodi O.S., Adami J., Linstrom D., et al. High body mass index is associated with increased risk of implant dislocation following primary total hip replacement: 2,106 patients followed for up to 8 years. Acta Orthop 79 (2008) 141
20. Choong P.F. Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampin based regimen. Acta Orthop 78 (2007) 755
21. Krishell R.J., and Fingeroth R.J. Primary total knee arthroplasty in morbidly obese patients: a 5-to 14-year follow-up study. J Arthroplasty 22 6 Suppl 2 (2007) 77 [Epub 2007 Jul 26]
22. Marchant MH, Bolognesi MP, Viens NA, et al. The impact of diabetes on perioperative patient outcomes after THA and TKR in the United States. AAOS 2008 San Francisco; Paper 576.
23. Bochicchio G.V., Joshi M., Bochicchio K.M., et al. Early hyperglycemic control is important in critically injured trauma patients. J Trauma 63 (2007) 1353
24. Ritter M.A., Harty L.D., Davis K.E., et al. Simultaneous bilateral, staged bilateral, and unilateral total knee arthroplasty. A survival analysis. J Bone Joint Surg Am 85-A (2003) 1532
25. Ritter M.A., Olberding E.M., and Malinzak R.A. Ultraviolet lighting during orthopaedic surgery and the rate of infection. J Bone Joint Surg Am 89 (2007) 1935
26. Wójkowska-Mach J., Jaje E., Romaniszyn D., et al. Comparison of SSI rates in endoarthroplasty of hip and knee in a Cracow patient population and the importance of postdischarge surveillance. Infection 36 (2008) 36 [Epub 2008 Jan 12]
27. Charnley J. Low friction arthroplasty of the hip (1979), Springer-Verlag 165
28. Furuya E.Y., Cook H.A., Lee M.H., et al. Community associated methicillin-resistant Staphylococcus aureus prevalence: how common is it? Methodological comparison of prevalence ascertainment. Am J Infect Control. 35 (2007) 359